UY33455A - Tableta con núcleo recubierto de liberación controlada - Google Patents

Tableta con núcleo recubierto de liberación controlada

Info

Publication number
UY33455A
UY33455A UY0001033455A UY33455A UY33455A UY 33455 A UY33455 A UY 33455A UY 0001033455 A UY0001033455 A UY 0001033455A UY 33455 A UY33455 A UY 33455A UY 33455 A UY33455 A UY 33455A
Authority
UY
Uruguay
Prior art keywords
cyano
methyl
inner core
tablet
thiazolecarboxylic acid
Prior art date
Application number
UY0001033455A
Other languages
English (en)
Inventor
Fujinaga Kentaro
Maruo Susumu
Nakamura Hideaki
Sunagawa Kenji
Mochizuki Tsutomu
Kageyama Michiharu
Original Assignee
Teijin Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teijin Pharma Ltd filed Critical Teijin Pharma Ltd
Publication of UY33455A publication Critical patent/UY33455A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se refiere a una tableta de liberación controlada que contiene un núcleo interno y una porción de capa externa que cubre el núcleo interno, la cual puede mantener la concentración de ácido 2-(3-ciano-4-isobutiloxifenil)-4-metil-5-tiazolcarboxílico en la sangre a un cierto nivel o superior durante un largo período de tiempo, donde el núcleo interno contiene ácido 2-(3-ciano-4-isobutiloxifenil)-4-metil-5-tiazolcarboxílico, y la porción de capa externa contiene ácido 2-(3-ciano-4-isobutiloxifenil)-4-metil-5-tiazolcarboxílico y un polímero hidrosoluble formador de gel.
UY0001033455A 2010-06-16 2011-06-15 Tableta con núcleo recubierto de liberación controlada UY33455A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2010137322 2010-06-16
JP2010137323 2010-06-16

Publications (1)

Publication Number Publication Date
UY33455A true UY33455A (es) 2012-01-31

Family

ID=45348267

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001033455A UY33455A (es) 2010-06-16 2011-06-15 Tableta con núcleo recubierto de liberación controlada

Country Status (9)

Country Link
US (1) US8968779B2 (es)
EP (1) EP2594269A4 (es)
JP (1) JP5669837B2 (es)
AR (1) AR081935A1 (es)
CA (1) CA2802831C (es)
MX (1) MX339452B (es)
TW (1) TW201206502A (es)
UY (1) UY33455A (es)
WO (1) WO2011158870A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105579037A (zh) 2013-05-31 2016-05-11 武田制药美国有限公司 用黄嘌呤氧化酶抑制剂治疗的方法和含黄嘌呤氧化酶抑制剂的组合物
CN111511353A (zh) 2017-06-21 2020-08-07 田边三菱制药株式会社 耐胃液的控释口服剂型
JP7377782B2 (ja) * 2019-09-04 2023-11-10 信越化学工業株式会社 フィルム成形用組成物及びフィルム
JP7506475B2 (ja) * 2019-12-26 2024-06-26 東和薬品株式会社 フェブキソスタット製剤

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3720757A1 (de) 1987-06-24 1989-01-05 Bayer Ag Dhp-manteltablette
JP3220373B2 (ja) 1995-11-28 2001-10-22 バイエル薬品株式会社 持続性ニフエジピン製剤
UA74141C2 (uk) * 1998-12-09 2005-11-15 Дж.Д. Сірл Енд Ко. Фармацевтична композиція на основі тонкоподрібненого еплеренону (варіанти), спосіб її одержання та спосіб лікування розладів, опосередкованих альдостероном (варіанти)
ATE307803T1 (de) 1999-01-22 2005-11-15 Boehringer Ingelheim Pharma Herstellung von 3-amino-2-chlor-4-methylpyridin aus aceton und ethylcyanoacetat
AP1243A (en) 1999-02-01 2004-02-02 Servier Lab Core tablet for controlled release of gliclazide after oral administration.
EG23951A (en) 1999-03-25 2008-01-29 Otsuka Pharma Co Ltd Cilostazol preparation
JP4637338B2 (ja) 2000-09-22 2011-02-23 大塚製薬株式会社 シロスタゾール有核錠
JP4817562B2 (ja) * 2001-09-26 2011-11-16 東和薬品株式会社 長時間持続型ニフエジピン有核錠
JP5105684B2 (ja) 2002-03-15 2012-12-26 大塚製薬株式会社 持続性医薬製剤
JP3751287B2 (ja) 2002-03-27 2006-03-01 バイエル薬品株式会社 小型化されたニフェジピン有核錠剤
ES2505690T3 (es) * 2002-03-28 2014-10-10 Teijin Pharma Limited Preparación sólida que contiene una forma única de cristal de un derivado de ácido tiazolcarboxílico
AU2003301121A1 (en) * 2002-12-18 2004-07-14 Pain Therapeutics, Inc. Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats
EP1915989A4 (en) * 2005-08-18 2012-05-30 Teijin Pharma Ltd PREPARATION WITH DIVISION FUNCTION IN ACCURATE DOSES
PE20070698A1 (es) * 2005-11-14 2007-08-17 Teijin Pharma Ltd Comprimido de disgregacion rapida intraoral que contiene hidrocloruro de ambroxol
ZA200805646B (en) 2005-12-28 2009-12-30 Takeda Pharmaceutical Controlled release solid preparation
CA2632962A1 (en) 2006-01-10 2007-07-19 Yasuhiro Takeda Sustained release preparation and method for production thereof
CA2687192C (en) * 2007-06-04 2015-11-24 Egalet A/S Controlled release pharmaceutical compositions for prolonged effect
US20100221335A1 (en) 2007-08-31 2010-09-02 Daiichi Sankyo Company, Limited Sustained-release preparation and method for producing the same
JP5351490B2 (ja) * 2007-10-25 2013-11-27 バイエル薬品株式会社 ニフェジピン含有有核錠剤およびその製法
KR20120096920A (ko) * 2009-06-26 2012-08-31 데이진 화-마 가부시키가이샤 고혈압증 또는 정상 고치 혈압증의 치료약
CN101671315B (zh) * 2009-08-19 2011-06-22 何广卫 非布索坦的新晶型及其制备方法
CN101658505A (zh) * 2009-09-29 2010-03-03 北京华禧联合科技发展有限公司 非布索坦的缓释制剂及其制备方法
AU2011268445B2 (en) * 2010-06-16 2015-05-07 Takeda Pharmaceuticals U.S.A., Inc. Novel modified release dosage forms of xanthine oxidoreductase inhibitor or xanthine oxidase inhibitors

Also Published As

Publication number Publication date
US20130089609A1 (en) 2013-04-11
CA2802831C (en) 2018-11-20
MX339452B (es) 2016-05-27
AR081935A1 (es) 2012-10-31
CA2802831A1 (en) 2011-12-22
EP2594269A1 (en) 2013-05-22
EP2594269A4 (en) 2013-12-04
JPWO2011158870A1 (ja) 2013-08-19
TW201206502A (en) 2012-02-16
MX2012014437A (es) 2013-02-26
JP5669837B2 (ja) 2015-02-18
US8968779B2 (en) 2015-03-03
WO2011158870A1 (ja) 2011-12-22

Similar Documents

Publication Publication Date Title
BR112013010078A2 (pt) sistema de prevenção de ferida de pressão e método para evitar o desenvolvimento de feridas de pressão de um indivíduo
CL2015003185A1 (es) Aparato para la electroobtención o electrorefinación
BR112015002864A2 (pt) conjunto de cateter e método de fornecer o conjunto de cateter.
BR112012000934A2 (pt) cassetes e métodos de utilizacao destes
BRPI0906549A2 (pt) Bandagens médicas com válvulas e kits contendo as mesmas.
CL2013001316A1 (es) Composicion que comprende micro-organismo probioticos no replicantes que protegen contra las infecciones del tracto respiratorio superior.
BR112013013414A2 (pt) dispositivos de coleta de sangue contendo agente de estabilização de sangue
BRPI0915147A2 (pt) retentor, mancal de esfera com sulco profundo e mancal com vedação
CL2009000299A1 (es) Sistema optico y procedimiento para detectar la presencia de un elemento biologico vivo; sensor biometrico de identificador de personas.
BRPI1009411A2 (pt) preparação externa contendo um agente analgésico/antiinflamatório
BRPI0821720A2 (pt) Aplicação de líquidos iônicos, magnéticos como agente de extração
CL2012003523A1 (es) Método para la preparación de una composición farmacéutica que contiene un portador de oxígeno termoestable; composicion farmaceutica que contiene un portador de oxigeno altamente purificado y termoestable.
FR2963357B1 (fr) Materiau photoluminescent contenant de l'ion d'argent
UY33455A (es) Tableta con núcleo recubierto de liberación controlada
AR086395A1 (es) Envase para el tratamiento de patologias
BRPI0922246A2 (pt) copolímero contendo blocos de construção ácida e vários tipos de blocos de construção de poliéter.
EA201270581A1 (ru) Фармацевтические композиции севеламера
BR112013010709A2 (pt) derivado de ácido trans-2-decenoico e agente farmacêutico contendo o mesmo
BRPI0924986A2 (pt) "combinações de substâncias ativas com propriedades inseticidas e acaricidas".
IT1401350B1 (it) Veicolo - ambulanza per il trasporto di pazienti, feriti e simili
FR2982277B1 (fr) Cassette d'expression inductible et ses utilisations
AR080933A1 (es) Tratamiento de esclerosis multiple con masitinib
IT1402427B1 (it) Metodo automatico di misura ed elaborazione della pressione sanguigna.
BR112012028736A2 (pt) bula de remédio e método de sua elaboração
ES2588766T3 (es) Cartucho de cinta inteligente

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20200807